 Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund jumped 4 by the afternoon, while the Defiance Nasdaq Junior Biotechnology ETF and the SPDR SP Biotech ETF both gained 3.5. 